Janux Therapeutics

JANX

JANX Janux Therapeutics NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    JANX Chart
    See on advanced chart >

    About

    Janux Therapeutics, Inc. was incorporated under the laws of the State of Delaware on June 27, 2017. The company is an innovative biopharmaceutical company developing next-generation therapeutics based on the company's proprietary Tumor Activated T Cell...
    • Highlight
      A clinical-stage biopharmaceutical company that developing immunotherapies for cancer
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      06/11/2021
    • Established Date
      06/27/2017
    • Full-time Employees
      64
    • Address
      10955 Vista Sorrento Parkway Suite 200 San Diego California 92130
    • Tel
      1-858-7514493
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock